StockData
Milestone Pharmaceuticals Inc. logo

Milestone Pharmaceuticals Inc. (MIST) stock

MISTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.41+0.05 (+13.21%)

Close on Nov 17, 2026Market cap $51.44MP/E –Yield –

Milestone Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Milestone Pharmaceuticals's price to book ratio was 4.5× on Nov 11, 2026, against 11.2× a year earlier. Over the last 5 years it ranged from 1.2× to 11.2×, with a median of 2.4×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20264.5×−3.9
2025Dec 31, 20258.4×+3.2
2024Dec 31, 20245.2×+3.3
2023Dec 29, 20232.0×+0.4
2022Dec 30, 20221.6×+0.0
2021Dec 31, 20211.5×−0.1
2020Dec 31, 20201.6×−1.3
2019Dec 31, 20193.0×–

More Milestone Pharmaceuticals figures

See a number that looks wrong?